Hot sale Etelcalcetide HCI raw powder match with US,EU, cGMP standard
TDS
1262780-97-1
Pharmaceutical Grade
99%
hangzhou
thinheal
1g/bag
2025-01-12
Tirzepatide,Linaclotide,Semaglutide,Plecanatide,Retatrutide,Eptifibatide
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceChEBI: Etelcalcetide is an oligopeptide.CertificatesBasic Info
-
Product Name:
Etelcalcetide
Other Name:Etelcalcetide;D-Argininamide, N-acetyl-D-cysteinyl-D-alanyl-D-arginyl-D-arginyl-D-arginyl-D-alanyl-, disulfide with L-cysteine;AMG-416 (Velcalcetide);Parsavib;S-(((S)-2-Acetamido-3-(((R)-1-(((R)-1-(((R)-1-(((R)-1-(((R)-1-(((R)-1-amino-5-guanidino-1-oxopentan-2-yl)amino)-1-oxopropan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-1-oxopropan-2-yl)amino)-3-oxopropyl)thio)-L-cysteine;Etelcalcetide HCI
CAS No.:1262780-97-1
Molecular Formula:C38H73N21O10S2
InChIKeys:HQGWMVNIZKNABK-TZUZSESWNA-N
Molecular Weight:1048.25
EC Number:204-259-2
Categories:
Characteristics-
Density:
1.58±0.1 g/cm3(Predicted)
PKA:2.01±0.10(Predicted)
Critical Temperature & Pressure:Store at -20°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Linaclotide,Semaglutide,Plecanatide,Retatrutide,Eptifibatide
-
Location:
8th Floor, Building 2, Heji R&D Center, Xiasha Street, Qiantang District, Hangzhou City, Zhejiang Province
-
Payment Terms:
TT against copy of documents,L/C,100% TT in advance
-
Average lead Time:
20 days
-
Total Annual Revenue:
$50 million-$100 million
-
Total Employees:
201-300
-
Year of Establishment:
2019
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Hot sale Exenatide acetate raw powder match with US,EU, cGMP standard
Pharmaceutical Grade / 99%
-
-
-
-
Hot sale Seractide ACTH (1-39) peptide raw powder match with US,EU, cGMP standard
Pharmaceutical Grade / 99%
-
-
-
-
Hot sale Dapiglutide raw powder match with US,EU, cGMP standard
Pharmaceutical Grade / 99%
-
-
-
-
Hot sale Semax raw powder match with US,EU, cGMP standard
Pharmaceutical Grade / 99%
-
-
-
-
Hot sale Abaloparatide raw powder match with US,EU, cGMP standard
Pharmaceutical Grade / 99%
-
-
-
-
Hot sale Mots-C raw powder match with US,EU, cGMP standard
Pharmaceutical Grade / 99%
-
